|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/30 | |
| C07K 16/28 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3400246 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17700491.8 |
| Europos patento paraiškos padavimo data | 2017-01-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-11-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/050168 |
| Data | 2017-01-05 |
| (87) | Numeris | WO 2017/118675 |
| Data | 2017-07-13 |
| (30) | Numeris | Data | Šalis |
| 16150506 | 2016-01-08 | EP |
| (72) |
BACAC, Marina, CH
COLOMBETTI, Sara, CH
KLEIN, Christian, CH
SAM, Johannes, CH
SARO, Jose, CH
UMAŃA, Pablo, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | METHODS OF TREATING CEA-POSITIVE CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-CEA/ANTI-CD3 BISPECIFIC ANTIBODIES |
| METHODS OF TREATING CEA-POSITIVE CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-CEA/ANTI-CD3 BISPECIFIC ANTIBODIES |